Supreme Court refuses to stop Kambala for now; final hearing on Mar 12

Bengaluru, May 3: Karnataka Education Minister S Suresh Kumar on Saturday said that those who want to travel from other states to Karnataka and vice-versa must register on 'Sevasindhu' website.

"Those who want to travel from other states to Karnataka and from Karnataka to other states must register on 'Sevasindhu' website, then all intimation will be shared from the government side," Kumar said.

Karnataka Health Department on Saturday said that three deaths and 12 new COVID-19 cases were reported in last 24 hours in the state.

According to the Health Department, the total number of coronavirus positive cases in the state is now 601. 271 patients have either been cured or discharged. The virus has killed 25 people so far in the state.

Mangaluru, Jul 26: Rubbishing reports about cancellation of institutional quarantine for international passengers in Mangaluru, local health authorities have clarified that 14 day isolation including first seven day institutional quarantine must for international passengers. 

For past couple of days rumours were doing rounds on social media that the government has done away with quarantine for international passengers. A few Mangaluru-based news portals also had published it as news without quoting any reliable sources. 

Meanwhile, district health officer in his clarification message said that neither Karnataka government nor Dakshina Kannada district administrant has revised the quarantine norms for international passengers. 

“Those who arrive from overseas must remain in isolation for 14 days. Out of this, seven days have to be spent in institutional quarantine (in hotel or lodge). During this period, the throat swab sample of the person will be sent for covid-19 testing. If the report is negative, then they will be sent to home quarantine for another seven days."

He said that concession in terms of number of days has only been given for people with other health conditions, children and the elderly. "For children below 10 years, pregnant women, elderly above the age of 60 years and other with other ailments, the throat swab will be collected on the second day of institutional quarantine. If the report turns negative, they will be sent to home quarantine for 14 days."

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.